Related Experiment Video
Updated: May 20, 2026

Multicellular Human Alveolar Model Composed of Epithelial Cells and Primary Immune Cells for Hazard Assessment
Published on: May 6, 2020
Membrane damage and repair in primary monocytes exposed to human β-defensin-3
Anthony B Lioi1, Angel L Reyes Rodriguez, Nicholas T Funderburg
1Department of Molecular Biology and Microbiology, Division of Infectious Diseases, Center for AIDS Research, Case Western Reserve University, Cleveland, OH 44106, USA.
Abstract:
Interactions of AMPs with plasma membranes of primary human immune cells are poorly characterized. Analysis of PI exclusion as a measure of membrane integrity indicated that hBD-3 caused membrane perturbations in monocytes but not T or B cells at concentrations typically used to kill bacteria or to induce activation of APCs. Bleb-like structures were observed in monocytes exposed to hBD-3. These cells also increased surface expression of LAMP1, a membrane repair marker after exposure to hBD-3. Furthermore, cell death was enhanced by adding an inhibitor of membrane repair. Removal of cholesterol from membranes resulted in greater susceptibility of cells to hBD-3, but cholesterol content was not different between the cell types, as assessed by filipin staining. Freshly isolated monocytes expressed higher levels of the negatively charged phospholipid, PS, on their outer leaflet compared with B or T cells. Preincubation of monocytes with molecules that bind PS protected these cells from hBD-3-induced membrane damage, suggesting that outer-membrane PS expression can at least partially explain monocyte susceptibility to hBD-3. The potential for membrane disruption caused by AMPs should be evaluated in various cell types when considering these molecules for therapeutic applications in humans.
Insights
Human immune cells, like monocytes, show varying susceptibility to antimicrobial peptides (AMPs). Negatively charged phospholipids on monocyte membranes contribute to their vulnerability to hBD-3, impacting therapeutic applications.
Area of Science:
- Immunology
- Cell Biology
- Biochemistry
Background:
- Interactions between antimicrobial peptides (AMPs) and human immune cell plasma membranes are not well understood.
- Understanding these interactions is crucial for evaluating AMPs as potential human therapeutics.
Purpose of the Study:
- To investigate the differential susceptibility of human immune cells (monocytes, T cells, B cells) to the antimicrobial peptide human beta-defensin 3 (hBD-3).
- To elucidate the membrane-related mechanisms underlying monocyte sensitivity to hBD-3.
Main Methods:
- Analysis of propidium iodide (PI) exclusion to assess membrane integrity.
- Microscopic observation of bleb formation and LAMP1 expression as a membrane repair marker.
- Assessment of cellular cholesterol content via filipin staining.
- Investigation of phosphatidylserine (PS) exposure and its role in hBD-3 susceptibility.
Main Results:
- hBD-3 caused membrane perturbations and bleb formation in monocytes, but not T or B cells, at relevant concentrations.
- Monocytes exhibited increased LAMP1 expression and enhanced cell death upon hBD-3 exposure, particularly when membrane repair was inhibited.
- Outer membrane phosphatidylserine (PS) exposure in monocytes was identified as a key factor contributing to their increased susceptibility to hBD-3-induced membrane damage.
Conclusions:
- Monocytes are more susceptible to hBD-3-induced membrane damage than T or B cells, partly due to higher surface expression of negatively charged PS.
- The findings highlight the importance of evaluating AMP-induced membrane disruption across diverse human immune cell types for therapeutic development.
- Targeting or understanding PS exposure could be critical for the safe and effective use of AMPs in human therapies.
More Related Videos
11:48Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes
Published on: May 31, 2018
10:55Analyzing the Communication Between Monocytes and Primary Breast Cancer Cells in an Extracellular Matrix Extract (ECME)-based Three-dimensional System
Published on: January 8, 2018